Bivalirudin, Human
357.20 $
For reserch purpose only
Shipping cost plus VAT not included , delivery in 7-14 business days
Catalog No
USB-B2102-50
Supplier
US Biologicals
Size
1 mg
Product Overview
Product Properties
Target Gene
Product Overview
| Description | Bivalirudin is a specific and reversible direct thrombin inhibitor. Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty. Human Bivalirudin is a synthetic 20 amino acid peptide. MW: 2180 Daltons Sequence (linear): Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly- Asp-Gly-Asp-Phe-Glu-Glu-Ile- Pro-Glu-Glu-Tyr-Leu Dimers and Aggregates: ≤ 1% as determined by silver-stained SDS-PAGE gel analysis. Protein Content: Protein quantitation was carried out by two independent methods: 1. UV spectroscopy at 280nm. 2. Analysis by RP-HPLC. Storage and Stability: Lyophilized powder may be stored at 4°C for short-term only. Stable for 12 months at -20°C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer. |
| Source Antigen | Synthetic |
| Reactivity | |
| Cross Reactivity | |
| Applications | |
| Molecular Weight |
Product Properties
| Storage | -20°C |
| Grade | Highly Purified |
| Purity | ≥ 95% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified. Endotoxin: < 0.1ng/ug (IEU/ug) of Bivalirudin. |
| Form | Supplied as a lyophilized powder in manntiol, sodium hydroxide, pH 5.5. Reconstitute with sterile ddH2O, 0.1% BSA or HSA to a concentration of >100ug/ml, which can then be further diluted to other aqueous solutions. |
| Reactivity Life | 12 months |
| Note | For reserch purpose only |
Target Gene
NA
